sjp-0132
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 31, 2019 (NCT04139122)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06717152 | Phase 3 | Dec 19, 2024 | Senju Pharmaceuticals |
| NCT04139122 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2019 | Senju Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Senju Pharmaceuticals | For profit | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1